Human T-cell epitopes of the latex allergen Hev b 5 in health care workers

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 1017-1024

  De Silva, Harini D ^a   Sutherland, Michael F ^a   Suphioglu, Cenk ^a   McLellan, Susan C ^a   Slater, Jay E ^b   Rolland, Jennifer M ^a   O'Hehir, Robyn E ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Allergen; Allergy; Hey b 5; Latex; Peptides; T cells; T cell epitopes

Indexed keywords

ALLERGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 5; LATEX;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITOPE MAPPING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN CELL; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE PROLIFERATION; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034071047     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.105806     Document Type: Article

References (37)

1. 1. Slater JE. Latex allergy. J Allergy Clin Immunol 1994;94:139-49.
2. 2. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated responses to latex. JAMA 1991;265:2844-7.
3. 3. Grzybowski M, Ownby DR, Peyser PA, Johnson CC, Schork MA. The prevalence of anti-latex IgE antibodies among registered nurses. J Allergy Clin Immunol 1996;98:535-44.
4. 4. Kibby T, Akl M. Prevalence of latex sensitization in a hospital employee population. Ann Allergy Asthma Immunol 1997;78:41-4.
5. 5. Liss GM, Sussman GL, Deal K, Brown S, Cividino M, Siu S, et al. Latex allergy: epidemiological study of 1351 hospital workers. Occup Environ Med 1997;54:335-42.
6. 6. Brown RH, Schauble JF, Hamilton RG. Prevalence of latex allergy among anesthesiologists: identification of sensitized but asymptomatic individuals. Anesthesiology 1998;89:292-9.
7. 7. Douglas R, Morton J, Czarny D, O'Hehir RE. Prevalence of IgE-mediated allergy to latex in hospital nursing staff. Aust N Z J Med 1997; 27:165-9.
8. 8. Michael T, Niggemann B, Moers A, Seidel U, Wahn U, Scheffner D. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996;26:934-9.
9. 9. Brugnami G, Marabini A, Siracusa A, Abbritti G. Work-related late asthmatic response induced by latex allergy. J Allergy Clin Immunol 1995;96:457-64.
10. 10. Ownby DR, Tomlanovich M, Sammons N, McCullough J. Anaphylaxis associated with latex allergy during barium enema examinations. AJR Am J Roentgenol 1991;156:903-8.
11. 11. Kelly KJ. Management of the latex allergic patient. Immunol Allergy Clin North Am 1995;15:139-57.
12. 12. Chen Z, Van Kampen V, Raulf-Heimsoth M, Baur X. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies. Clin Exp Allergy 1996;26:406-15.
13. 13. Yeang HY, Cheong KF, Sunderasan E, Hamzah S, Chew NP, Hamid S, et al. The 14.6 kd rubber elongation factor (Hev b 1) and 24 kd (Hev b 3) rubber particle proteins are recognized by IgE from patients with spina bifida and latex allergy. J Allergy Clin Immunol 1996;98:628-39.
14. 14. Sowka S, Wagner S, Krebitz M, Arija-Mad-Arifs S, Yusof F, Kinaciyan T, et al. cDNA cloning of the 43-kDa latex allergen Hev b 7 with sequence similarity to patatins and its expression in the yeast Pichia pastoris. Eur J Bioch 1998;255:213-9.
15. 15. Scheiner O, Wagner B, Wagner S, Krebitz M, Crameri R, Niggeman B, et al. Cloning and molecular characterization of Hev b 3, a spina bifida-associated allergen from Hevea brasiliensis latex. Int Arch Allergy Immunol 1999;118:311-2.
16. 16. Kostyal DA, Hickey VL, Noti JD, Sussman GL, Beezhold DH. Cloning and characterization of a latex allergen (Hev b 7): homology to patatin, a plant PLA2. Clin Exp Immunol 1998;112:355-62.
17. 17. Akasawa A, Hsieh LS, Martin BM, Liu T, Lin Y. A novel acidic allergen, Hev b 5, in latex: purification, cloning and characterization. J Biol Chem 1996;271:25389-93.
18. 18. Slater JE, Vedvick T, Arthur-Smith A, Trybul DE, Kekwick RG. Identification, cloning, and sequence of a major allergen (Hev b 5) from natural rubber latex (Hevea brasiliensis). J Biol Chem 1996;271:25394-9.
19. 19. Chen Z, Posch A, Cremer R, Raulf-Heimsoth M, Baur X. Identification of hevein (Hev b 6.02) in Hevea latex as a major cross-reacting allergen with avocado fruit in patients with latex allergy. J Allergy Clin Immunol 1998;102:476-81.
20. 20. Posch A, Chen Z, Raulf-Heimsoth M, Baur X. Latex allergens. Clin Exp Allergy 1998;28:134-40.
21. 21. Breitender H. The allergens of Hevea brasiliensis. Allergy Clin Immunol Int 1998;10:101-9.
22. 22. Brehler R, Theissen U, Mohr C, Luger T. "Latex-fruit syndrome": frequency of cross-reacting IgE antibodies. Allergy 1997;52:404-10.
23. 23. Raulf-Heimsoth M, Chen Z, Rihs HP, Kalbacher H, Liebers V, Baur X. Analysis of T-cell reactive regions and HLA-DR4 binding motifs on the latex allergen (Hev b 1) rubber elongation factor. Clin Exp Allergy 1998;28:339-48.
24. 24. Suphioglu C, Singh M, Simpson R, Ward L, Knox B. Identification of canary grass (Phalaris aquatica) pollen allergens by immunoblotting; IgE and IgG antibody binding studies. Allergy 1993;48:273-81.
25. 25. O'Hehir RE, Young DB, Kay AB, Lamb JR. Cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite): a comparison of T and B cell antigen recognition. Immunology 1987;62:635-40.
26. 26. O'Hehir RE, Askonas BA, Lamb JR. Cell culture: lymphocyte clones. In: Albert WHW, Staines NA, editors. Methods of immunological analysis. Vol 3. Heidelberg: Springer-Verlag; 1993. p 120-38.
27. 27. Beezhold DH, Hickey VL, Slater JE, Sussman GL. Human IgE-binding epitopes of the latex allergen Hev b 5. J Allergy Clin Immunol 1999;103:1166-72.
28. 28. Sette A, Sidney J. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol 1998;10:478-82.
29. 29. De Lalla C, Sturniolo T, Abbruzzese L, Hammer J, Siddoli A, Sinigaglia F, et al. Identification of novel T cell epitopes in Lol p 5a by computational prediction. J Immunol 1999;163:1725-9.
30. 30. Ramachandram S, Thompson R, Gam A, Neva F. Recombinant cDNA clones for the immunodiagnosis of strongyloidiasis. J Infect Dis 1998;177:196-203.
31. 31. Moller M, Kayma M, Vieluf D, Paschke A, Steinhart H. Determination and characterization of cross-reacting allergens in latex, avocado, banana and kiwi fruit. Allergy 1998;53:289-96.
32. 32. Hoyne G, Jarnicki A, Thomas W, Lamb J. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression. Int Immunol 1997;9:1165-73.
33. 33. Slater JE, Paupore EJ, O'Hehir RE. Murine B-cell and T-cell epitopes of the allergen Hev b 5 from natural rubber latex. Mol Immunol 1999;36:135-43.
34. 34. O'Hehir RE, Hoyne GF, Thomas WR, Lamb JR. House dust mite allergy: from T cell epitopes to immunotherapy. Eur J Clin Invest 1993;23:763-72.
35. 35. Schramm G, Kahlert H, Suck R, Weber B, Stuwe H, Muller W, et al. "Allergen engineering": variants of the timothy grass pollen allergen phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity. J Immunol 1999;162:2406-14.
36. 36. Muller U, Akdis C, Fricker M, Akdis M, Blesken T, Betens F, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-54.
37. 37. Simons FER, Imada M, Li Y, Hayglass KT. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat allergic human subjects. Int Immunol 1996;8:1937-45.